Form4insider filings, from the source

SEC Form 3 · accession 0001144204-15-019517

Bionik Laboratories Corp. · BNKL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 20, 2015
Accepted (ET)
Mar 30, 2015 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareholding———125,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Option to Buy)F4,F1,F2,F3$0.23holding————Feb 16, 2022Exchangeable Shares62,915—D

Explanation of responses